Safety Surveillance of Covishield Vaccine-Associated Adverse Events During the COVID-19 Pandemic: A Retrospective Longitudinal Study
The data suggest that the Covishield vaccine had mild to moderate adverse effects on the study population. This pharmacovigilance study will complement safety data and aid in the benefit-risk analysis of adverse effects associated with the Covishield vaccine. Additionally, healthcare professionals should be encouraged to conduct further safety studies by establishing robust vaccine safety monitoring systems in hospitals. Continuing medical education and workshops should also be conducted to educate healthcare workers about active surveillance.
Authors
- Monica Aggarwal (ORCID: https://orcid.org/0000-0002-7027-0060)
- Girish Gulab Meshram (ORCID: https://orcid.org/0000-0003-1499-9970)
- Minakshi Garg (ORCID: https://orcid.org/0000-0002-5065-0832)
- Rohit Dhaka
- Shilpa Chaudhary
- Gopal Vishwas
- Puja Kumari (ORCID: https://orcid.org/0000-0002-6076-4681)
Institutions
- Rajendra Memorial Research Institute of Medical Sciences (IN)
- Maulana Azad Medical College (IN)
- Delhi Pharmaceutical Science and Research University (IN)
- Employees' State Insurance Model Hospital (IN)
Publication Details
- Journal
- Cureus
- Published
- 2024-08-19
- DOI
- https://doi.org/10.7759/cureus.67257
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00